Literature DB >> 27295058

The Validation Study of Neurofilament Heavy Chain and 8-hydroxy-2'-deoxyguanosine as Plasma Biomarkers of Clinical/Paraclinical Activity in First and Relapsing-Remitting Demyelination Acute Attacks.

S Ljubisavljevic1,2, I Stojanovic3, J Basic3, D A Pavlovic3.   

Abstract

Although current evidence mainly suggests immunopathogenesis of demyelination and neurodegeneration in multiple sclerosis (MS), there are results which document the importance of other factors, such as oxidative stress and its mediated injuries. The oxidative stress intensity in axonal damage during acute demyelination is little known. We performed this study as a cross-sectional biomarker validation study in order to evaluate the parameters of axonal damage (phosphorylated neurofilaments heavy chain (pNF-H)) and oxidative stress (8-hydroxy-2'-deoxyguanosine (8-OHdG)) in plasma of patients with initial and relapsing-remitting demyelination attacks, defined as clinically isolated syndrome (CIS) and relapsing-remitting multiple sclerosis (RRMS); and the correlations between these parameters and biological (index of blood brain barrier (BBB) permeability), clinical (index of disease progression), and radiological (T1-Gd-enhancing lesion volume) activities of disease. Both parameters were increased in CIS and RRMS compared to control subjects (p < 0.05). The positive correlations were observed between 8-OHdG values and index of BBB permeability, clinical severity of disease, and demyelinated brain lesion volume, in CIS group (r > 0.50; p < 0.05). Similar correlations were obtained between pNF-H values and the above parameters, as well as the index of disease progression, in RRMS group (r > 0.30; p < 0.05). There was a significant correlation between values of 8-OHdG and pNF-H only in CIS group, r = 0.52, p < 0.05. While the plasma values of 8-OHdG reflect the degree of acute demyelination in CIS, pNF-H values reflect that in RRMS. The obtained results must be reevaluated in similar prospective studies related to their prognostic values.

Entities:  

Keywords:  8-hydroxy-2′-deoxyguanosine; Demyelination; Neurofilament heavy chain

Mesh:

Substances:

Year:  2016        PMID: 27295058     DOI: 10.1007/s12640-016-9639-z

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  29 in total

Review 1.  Neurofilaments as biomarkers in multiple sclerosis.

Authors:  Charlotte E Teunissen; Michael Khalil
Journal:  Mult Scler       Date:  2012-04-04       Impact factor: 6.312

Review 2.  Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.

Authors:  Ranjan Dutta; Bruce D Trapp
Journal:  Prog Neurobiol       Date:  2010-10-12       Impact factor: 11.685

3.  Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.

Authors:  Martin Gunnarsson; Clas Malmeström; Markus Axelsson; Peter Sundström; Charlotte Dahle; Magnus Vrethem; Tomas Olsson; Fredrik Piehl; Niklas Norgren; Lars Rosengren; Anders Svenningsson; Jan Lycke
Journal:  Ann Neurol       Date:  2010-12-08       Impact factor: 10.422

4.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

5.  Evidence for acute neurotoxicity after chemotherapy.

Authors:  Axel Petzold; Tjeerd Mondria; Jens Kuhle; Maria A Rocca; Jan Cornelissen; Peter te Boekhorst; Bob Lowenberg; Gavin Giovannoni; Massimo Filippi; Ludwig Kappos; Rogier Hintzen
Journal:  Ann Neurol       Date:  2010-12       Impact factor: 10.422

Review 6.  Markers of oxidant stress that are clinically relevant in aging and age-related disease.

Authors:  Kimberly D Jacob; Nicole Noren Hooten; Andrzej R Trzeciak; Michele K Evans
Journal:  Mech Ageing Dev       Date:  2013-02-18       Impact factor: 5.432

7.  Protective effects of cyclosativene on H2O 2-induced injury in cultured rat primary cerebral cortex cells.

Authors:  Hasan Turkez; Basak Togar; Antonio Di Stefano; Numan Taspınar; Piera Sozio
Journal:  Cytotechnology       Date:  2014-02-04       Impact factor: 2.058

Review 8.  Axonal damage: a key predictor of outcome in human CNS diseases.

Authors:  I M Medana; M M Esiri
Journal:  Brain       Date:  2003-03       Impact factor: 13.501

Review 9.  Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.

Authors:  Manuel A Friese; Benjamin Schattling; Lars Fugger
Journal:  Nat Rev Neurol       Date:  2014-03-18       Impact factor: 42.937

10.  Oxidative damage in multiple sclerosis lesions.

Authors:  Lukas Haider; Marie T Fischer; Josa M Frischer; Jan Bauer; Romana Höftberger; Gergö Botond; Harald Esterbauer; Christoph J Binder; Joseph L Witztum; Hans Lassmann
Journal:  Brain       Date:  2011-06-07       Impact factor: 13.501

View more
  4 in total

1.  Autologous Bone Marrow Transplantation in Multiple Sclerosis: Biomarker Relevance for Patient Recruitment and Follow up.

Authors:  Ana C Londoño; Carlos A Mora
Journal:  J Clin Cell Immunol       Date:  2016-09-20

Review 2.  Biomarkers of multiple sclerosis: current findings.

Authors:  Violaine K Harris; John F Tuddenham; Saud A Sadiq
Journal:  Degener Neurol Neuromuscul Dis       Date:  2017-01-12

Review 3.  Genetic, Environmental and Lifestyle Determinants of Accelerated Telomere Attrition as Contributors to Risk and Severity of Multiple Sclerosis.

Authors:  Michael Hecker; Jan Bühring; Brit Fitzner; Paulus Stefan Rommer; Uwe Klaus Zettl
Journal:  Biomolecules       Date:  2021-10-13

4.  Cellular metabolism and oxidative stress as a possible determinant for longevity in small breed and large breed dogs.

Authors:  Ana Gabriela Jimenez; Josh Winward; Ursula Beattie; William Cipolli
Journal:  PLoS One       Date:  2018-04-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.